4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-013339
Chief Accounting Officer acquired 17,442 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-18 | Grant or award : show line 1 in the form | +17,442 | 80,644 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-01-18 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +42,558 | $9.15 | 2032-01-18 | 42,558 | 42,558 | D |
Loading xslF345X03/doc4.xml…